Influences of tobacco and alcohol use on hepatocellular carcinoma survival

International Journal of Cancer

Volumn 131, Issue 11, 2012, Pages 2612-2621

  Shih, Wei Liang ^a   Chang, Hung Chuen ^a,b   Liaw, Yun Fan ^c   Lin, Shi Ming ^c   Lee, Shou Dong ^d   Chen, Pei Jer ^e   Liu, Chun Jen ^e   Lin, Chih Lin ^f   Yu, Ming Whei ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

alcohol consumption; cigarette smoking; hepatitis virus infection; hepatocellular carcinoma; survival

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; INTERVIEW; LIFESTYLE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; TAIWAN;

EID: 84983725611     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27508     Document Type: Article

References (34)

1. Jemal A, Center MM, DeSantis C, Ward EM,. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893-1907.
2. Tandon P, Garcia-Tsao G,. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009; 29: 502-10.
3. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y,. Liver Cancer Study Group of Japan. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131: 461-69.
4. Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, Chiou YY, Chiang JH, Lee PC, Huo TI, Lee SD,. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol 2010; 53: 108-17.
5. Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M,. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006; 44: 1518-27.
6. Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC,. Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA 1996; 275: 1646-50.
7. Jee SH, Ohrr H, Sull JW, Samet JM,. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004; 96: 1851-56.
8. Yu MC, Tong MJ, Govindarajan S, Henderson BE,. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991; 83: 1820-26.
9. Tanaka K, Hirohata T, Takeshita S, Hirohata I, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Ishibashi H,. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer 1992; 51: 509-14.
10. La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S,. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 1988; 42: 872-76.
11. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T,. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-1801.
12. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, Decarli A, Trevisi P, Ribero ML, Martelli C, Porru S, Nardi G,. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155: 323-31.
13. Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF, Schnohr P, Jensen G,. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996; 23: 1025-29.
14. Morgan TR, Mandayam S, Jamal MM,. Alcohol and hepatocellular carcinoma. Gastroenterology 2004; 127 (5 Suppl 1): S87-96.
15. Pulling LC, Klinge DM, Belinsky SA,. p16INK4a and beta-catenin alterations in rat liver tumors induced by NNK. Carcinogenesis 2001; 22: 461-66.
16. Hutt JA, Vuillemenot BR, Barr EB, Grimes MJ, Hahn FF, Hobbs CH, March TH, Gigliotti AP, Seilkop SK, Finch GL, Mauderly JL, Belinsky SA,. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis 2005; 26: 1999-2009.
17. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA,. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 2004; 64: 3844-48.
18. Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH,. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 2004; 25: 2165-71.
19. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF, Wang YC,. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 2010; 120: 521-32.
20. Park SM, Lim MK, Shin SA, Yun YH,. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006; 24: 5017-24.
21. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A,. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-9.
22. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L,. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-99.
23. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W,. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 2006; 106: 1276-85.
24. He Y,. Missing data analysis using multiple imputation: getting to the heart of the matter. Circ Cardiovasc Qual Outcomes 2010; 3: 98-105.
25. Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA,. Smoking and smoking cessation in relation to mortality in women. JAMA 2008; 299: 2037-47.
26. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE,. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-39.
27. Wakai K, Marugame T, Kuriyama S, Sobue T, Tamakoshi A, Satoh H, Tajima K, Suzuki T, Tsugane S,. Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies. Cancer Sci 2007; 98: 584-89.
28. Parsons A, Daley A, Begh R, Aveyard P,. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569.
29. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Jr, Doll R,. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997; 337: 1705-14.
30. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Jr,. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-78.
31. Belinsky SA, Devereux TR, Maronpot RR, Stoner GD, Anderson MW,. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res 1989; 49: 5305-11.
32. Prieto J,. Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol 2008; 48: 380-81.
33. Altamirano J, Bataller R,. Cigarette smoking and chronic liver diseases. Gut 2010; 59: 1159-62.
34. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P,. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-15.